Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
June 29, 2021 10:19 AM 3 min read

Want to Buy CNS Pharmaceuticals (NASDAQ: CNSP) Stock? Read This First.

by Patton Hunnicutt
Follow
CNSP Logo
CNSPCNS Pharmaceuticals Inc
$4.42-2.00%
Overview

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

CNS Pharmaceuticals (NASDAQ:CNSP) is a pre-clinical biotech company focusing on treatments for brain tumors. The firm holds the exclusive worldwide license for its main product, Berubicin, and plans to develop the drug to treat other conditions.

Step 1: Open up a brokerage account.

Opening a brokerage account is the first step in your investment journey. You can choose from this list of brokers curated by Benzinga and quickly register. Brokerage houses require your personal information for tax purposes, financial information to fund the account and may ask you to verify your identity. You must also choose the appropriate account style given the commissions you prefer to pay or bonuses/options the broker offers.

 

 

Step 2: Select your number of shares. 

The number of shares you purchase depends entirely on your budget. The money you allocate to the stock market—or any other investment—lets you know how many shares you can buy.

If you want to spend all your money on CNSP shares, so be it. You might also allocate a percentage of those funds to CNSP while the rest is spent on other financial tools.

Step 3: Choose an order type.

When choosing an order type, remember that you can do more than buy and sell stocks. A Market Order allows you to buy and sell normally, but there are other orders that help you trade without doing all the work yourself.

A Stop-Limit Order allows you to set a limit and sell when the price gets high enough to ensure profits. Stop-Loss orders sell at a predetermined price to prevent losses. You can also set up orders to complete immediately or cancel if that is not possible, etc.

Step 4: Execute your trade.

At the time of your trade, you see everything change in an instant. You know how much money is left in your account, how many shares you hold and the totality of your portfolio. For this reason, it is wise to review your account just after a transaction to better understand your current position.

CNSP History

Benzinga Pro offers you all the information you need on CNS Pharmaceuticals or any other stock. You can diversify your portfolio and increase your net worth using these advanced tools, research and a little common sense.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Penny StocksMarkets

Broker

Best For

Overall Rating

Start Trading

Webull

Intermediate Traders

4.5 Stars

Get Started

Interactive Brokers

Lowest Fees

5 Stars

Get Started

Robinhood

Beginner Traders

4 Stars

Get Started

Moomoo

Active Traders

5 Stars

Get Started

TD Ameritrade

Day Traders

5 Stars

Get Started

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.

 

CNSP Logo
CNSPCNS Pharmaceuticals Inc
$4.42-2.00%
Overview
Comments
Loading...